Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
Johnson and Johnson
Queensland Health
Colorcon
Fish and Richardson
Dow
Medtronic
Mallinckrodt

Generated: November 19, 2018

DrugPatentWatch Database Preview

Rigel Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for RIGEL PHARMS INC, and what generic alternatives to RIGEL PHARMS INC drugs are available?

RIGEL PHARMS INC has one approved drug.

There are fourteen US patents protecting RIGEL PHARMS INC drugs.

Summary for Rigel Pharms Inc
US Patents:14
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Rigel Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rigel Pharms Inc TAVALISSE fostamatinib disodium TABLET;ORAL 209299-002 Apr 17, 2018 RX Yes Yes 8,951,504 ➤ Try a Free Trial ➤ Try a Free Trial
Rigel Pharms Inc TAVALISSE fostamatinib disodium TABLET;ORAL 209299-001 Apr 17, 2018 RX Yes No 8,652,492 ➤ Try a Free Trial Y ➤ Try a Free Trial
Rigel Pharms Inc TAVALISSE fostamatinib disodium TABLET;ORAL 209299-001 Apr 17, 2018 RX Yes No 8,912,170 ➤ Try a Free Trial ➤ Try a Free Trial
Rigel Pharms Inc TAVALISSE fostamatinib disodium TABLET;ORAL 209299-002 Apr 17, 2018 RX Yes Yes 7,989,448 ➤ Try a Free Trial Y ➤ Try a Free Trial
Rigel Pharms Inc TAVALISSE fostamatinib disodium TABLET;ORAL 209299-002 Apr 17, 2018 RX Yes Yes 7,449,458 ➤ Try a Free Trial Y ➤ Try a Free Trial
Rigel Pharms Inc TAVALISSE fostamatinib disodium TABLET;ORAL 209299-002 Apr 17, 2018 RX Yes Yes 7,538,108 ➤ Try a Free Trial Y ➤ Try a Free Trial
Rigel Pharms Inc TAVALISSE fostamatinib disodium TABLET;ORAL 209299-002 Apr 17, 2018 RX Yes Yes 8,445,485 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Rigel Pharms Inc Drugs

Country Document Number Estimated Expiration
Uruguay 34223 ➤ Try a Free Trial
Japan 4801096 ➤ Try a Free Trial
Canada 2673137 ➤ Try a Free Trial
Australia 2012288632 ➤ Try a Free Trial
Eurasian Patent Organization 020210 ➤ Try a Free Trial
Cuba 23915 ➤ Try a Free Trial
Mexico 2010004733 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Federal Trade Commission
Fish and Richardson
Johnson and Johnson
AstraZeneca
Cantor Fitzgerald
Moodys
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.